Latest Insider Transactions at Pacira Bio Sciences, Inc. (PCRX)
This section provides a real-time view of insider transactions for Pacira Bio Sciences, Inc. (PCRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Pacira BioSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Pacira BioSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2021
|
Mark Froimson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+14.46%
|
-
|
|
Jun 09
2021
|
Yvonne Greenstreet Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+8.1%
|
-
|
|
Jun 09
2021
|
Paul J Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+13.99%
|
-
|
|
Jun 09
2021
|
Mark A. Kronenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+5.99%
|
-
|
|
Jun 09
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+21.42%
|
-
|
|
Jun 09
2021
|
John P Phd Longenecker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+5.36%
|
-
|
|
Jun 09
2021
|
Donald C. Manning Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.89%
|
-
|
|
Jun 09
2021
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+18.4%
|
-
|
|
Jun 09
2021
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+20.02%
|
-
|
|
Jun 09
2021
|
David M Stack CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+18.4%
|
-
|
|
Jun 09
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+15.0%
|
-
|
|
Jun 09
2021
|
Charles A. Reinhart Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.3%
|
-
|
|
Jun 09
2021
|
Max Reinhardt President, Rest of World |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+28.57%
|
-
|
|
Jun 09
2021
|
Dennis Mc Loughlin Chief Customer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+15.17%
|
-
|
|
Jun 09
2021
|
Gary W Pace Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+0.82%
|
-
|
|
Jun 08
2021
|
Donald C. Manning Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,600
-9.95%
|
$158,600
$61.14 P/Share
|
|
Jun 07
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
2,278
-17.83%
|
$136,680
$60.5 P/Share
|
|
Jun 04
2021
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
630
-10.3%
|
$39,060
$62.19 P/Share
|
|
Jun 04
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,117
-10.18%
|
$129,137
$61.04 P/Share
|
|
Jun 04
2021
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
1,895
-6.44%
|
$115,595
$61.04 P/Share
|
|
Jun 04
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,222
-8.73%
|
$74,542
$61.04 P/Share
|
|
Jun 04
2021
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,648
-9.65%
|
$161,528
$61.04 P/Share
|
|
Jun 04
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,047
-7.94%
|
$63,867
$61.04 P/Share
|
|
Jun 04
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
14,905
-19.6%
|
$909,205
$61.04 P/Share
|
|
Jun 04
2021
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,930
-15.79%
|
$239,730
$61.04 P/Share
|
|
Jun 04
2021
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,276
-8.65%
|
$138,836
$61.04 P/Share
|
|
Jun 02
2021
|
Donald C. Manning Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,380
-8.35%
|
$147,560
$62.12 P/Share
|
|
May 13
2021
|
Gary W Pace Director |
SELL
Bona fide gift
|
Direct |
1,485
-1.14%
|
-
|
|
May 12
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
21,250
-7.71%
|
$1,296,250
$61.75 P/Share
|
|
May 12
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+17.92%
|
$212,500
$10.81 P/Share
|
|
May 11
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
21,250
-11.56%
|
$1,275,000
$60.98 P/Share
|
|
May 11
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+17.92%
|
$212,500
$10.81 P/Share
|
|
Apr 13
2021
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
21,823
-26.85%
|
$1,462,141
$67.26 P/Share
|
|
Apr 13
2021
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,823
+12.47%
|
$851,097
$39.61 P/Share
|
|
Mar 31
2021
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,224
-17.52%
|
$1,577,904
$71.19 P/Share
|
|
Mar 31
2021
|
Roy Winston Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+22.08%
|
$467,500
$34.38 P/Share
|
|
Mar 24
2021
|
David M Stack CEO and Chairman |
SELL
Bona fide gift
|
Indirect |
1,080
-1.1%
|
-
|
|
Mar 17
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,000
-13.17%
|
$140,000
$70.01 P/Share
|
|
Mar 17
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.64%
|
$20,000
$10.81 P/Share
|
|
Mar 15
2021
|
Mark Froimson Director |
SELL
Open market or private sale
|
Direct |
734
-12.28%
|
$52,848
$72.26 P/Share
|
|
Mar 15
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,520
-10.34%
|
$110,960
$73.28 P/Share
|
|
Mar 15
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
1,520
+9.37%
|
$15,200
$10.81 P/Share
|
|
Mar 15
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
10,601
-2.3%
|
$773,873
$73.68 P/Share
|
|
Mar 12
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
58,754
-11.28%
|
$4,289,042
$73.1 P/Share
|
|
Mar 11
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
60,574
-10.42%
|
$4,361,328
$72.7 P/Share
|
|
Mar 10
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
76,480
-11.63%
|
$5,430,080
$71.78 P/Share
|
|
Mar 09
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
35,137
-5.07%
|
$2,459,590
$70.9 P/Share
|
|
Mar 05
2021
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
3,000
-32.91%
|
$195,000
$65.88 P/Share
|
|
Mar 05
2021
|
Paul J Hastings Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+24.76%
|
$39,000
$13.98 P/Share
|
|
Mar 01
2021
|
John P Phd Longenecker Director |
SELL
Open market or private sale
|
Direct |
5,000
-21.97%
|
$360,000
$72.26 P/Share
|